
Humana (HUM) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
32.1B
Net Income
1.2B
3.87%
Balance Sheet Metrics
Total Assets
50.9B
Total Liabilities
33.1B
Shareholders Equity
17.8B
Debt to Equity
1.86
Cash Flow Metrics
Operating Cash Flow
66.0M
Free Cash Flow
236.0M
Revenue & Profitability Trend
Humana Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 117.8B | 106.4B | 92.9B | 83.1B | 77.2B |
Cost of Goods Sold | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | - | - | - | 10.1B |
Other Operating Expenses | 13.9B | 13.3B | 12.7B | 9.6B | 10.2B |
Total Operating Expenses | 13.9B | 13.3B | 12.7B | 9.6B | 20.2B |
Operating Income | - | - | - | - | - |
Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 660.0M | 493.0M | 401.0M | 326.0M | 283.0M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 1.7B | 3.4B | 3.6B | 3.4B | 4.6B |
Income Tax | 413.0M | 836.0M | 762.0M | 485.0M | 1.3B |
Effective Tax Rate % | 24.0% | 24.7% | 21.4% | 14.5% | 28.4% |
Net Income | 1.2B | 2.5B | 2.8B | 2.9B | 3.4B |
Net Margin % | 1.0% | 2.3% | 3.0% | 3.5% | 4.4% |
Key Metrics | |||||
EBITDA | - | - | - | - | - |
EPS (Basic) | $10.01 | $20.09 | $22.20 | $22.79 | $25.47 |
EPS (Diluted) | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 |
Basic Shares Outstanding | 120571000 | 123866000 | 126419000 | 128687998 | 132198998 |
Diluted Shares Outstanding | 120571000 | 123866000 | 126419000 | 128687998 | 132198998 |
Income Statement Trend
Humana Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 2.2B | 4.7B | 5.1B | 3.4B | 4.7B |
Short-term Investments | 18.2B | 16.6B | 13.9B | 13.2B | 12.6B |
Accounts Receivable | 2.7B | 2.0B | 1.7B | 1.8B | 1.1B |
Inventory | - | - | - | - | - |
Other Current Assets | - | - | - | - | - |
Total Current Assets | - | - | - | - | - |
Non-Current Assets | |||||
Property, Plant & Equipment | - | - | - | - | - |
Goodwill | 20.7B | 20.8B | 20.0B | 24.8B | 9.2B |
Intangible Assets | 1.4B | 1.7B | 1.8B | 2.6B | 329.0M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | - | - |
Total Non-Current Assets | - | - | - | - | - |
Total Assets | 46.5B | - | - | - | - |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 15.7B | 16.8B | 14.5B | 12.8B | 12.2B |
Short-term Debt | 577.0M | 1.4B | 3.2B | 2.0B | 600.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | - | - | - | - | - |
Non-Current Liabilities | |||||
Long-term Debt | 11.1B | 10.2B | 7.9B | 10.5B | 6.1B |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | - | - | - | - | - |
Total Liabilities | 30.0B | - | - | - | - |
Equity | |||||
Common Stock | 33.0M | 33.0M | 33.0M | 33.0M | 33.0M |
Retained Earnings | 28.3B | 27.5B | 25.5B | 23.1B | 20.5B |
Treasury Stock | 14.4B | 13.7B | 12.2B | 10.2B | 9.9B |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 16.4B | 16.3B | 15.4B | 16.1B | 13.7B |
Key Metrics | |||||
Total Debt | 11.7B | 11.7B | 11.1B | 12.5B | 6.7B |
Working Capital | 0 | 0 | 0 | 0 | 0 |
Balance Sheet Composition
Humana Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 1.2B | 2.5B | 2.8B | 2.9B | 3.4B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 207.0M | 175.0M | 216.0M | 180.0M | 181.0M |
Working Capital Changes | 154.0M | 81.0M | 534.0M | -556.0M | 2.1B |
Operating Cash Flow | 1.5B | 2.7B | 3.5B | 2.6B | 5.9B |
Investing Activities | |||||
Capital Expenditures | -568.0M | -794.0M | -1.1B | -1.3B | -964.0M |
Acquisitions | -89.0M | -233.0M | 2.4B | -4.2B | -709.0M |
Investment Purchases | -8.2B | -7.6B | -6.0B | -7.2B | -9.1B |
Investment Sales | 6.4B | 5.1B | 3.8B | 6.1B | 7.7B |
Investing Cash Flow | -3.0B | -3.5B | -1.0B | -6.6B | -3.1B |
Financing Activities | |||||
Share Repurchases | -817.0M | -1.6B | -2.1B | -79.0M | -1.8B |
Dividends Paid | -431.0M | -431.0M | -392.0M | -354.0M | -323.0M |
Debt Issuance | 2.2B | 2.5B | 2.0B | 5.5B | 2.1B |
Debt Repayment | -2.0B | -2.4B | -3.4B | -2.1B | -1.4B |
Financing Cash Flow | -3.8B | -956.0M | -2.3B | 3.0B | -2.0B |
Free Cash Flow | 2.4B | 3.0B | 3.4B | 920.0M | 4.7B |
Net Change in Cash | -5.3B | -1.8B | 226.0M | -928.0M | 915.0M |
Cash Flow Trend
Humana Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
21.59
Forward P/E
16.75
Price to Book
1.86
Price to Sales
0.28
PEG Ratio
16.75
Profitability Ratios
Profit Margin
1.28%
Operating Margin
3.58%
Return on Equity
9.03%
Return on Assets
4.69%
Financial Health
Current Ratio
1.95
Debt to Equity
70.63
Beta
0.45
Per Share Data
EPS (TTM)
$13.06
Book Value per Share
$151.61
Revenue per Share
$1,021.52
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
hum | 33.9B | 21.59 | 1.86 | 9.03% | 1.28% | 70.63 |
UnitedHealth | 244.5B | 11.69 | 2.58 | 21.65% | 5.04% | 75.58 |
CVS Health | 87.0B | 19.11 | 1.12 | 5.88% | 1.18% | 106.67 |
Cigna | 79.2B | 16.28 | 1.97 | 13.18% | 1.92% | 76.10 |
Elevance Health | 69.7B | 13.14 | 1.59 | 12.42% | 2.83% | 68.84 |
Centene | 14.0B | 6.92 | 0.51 | 7.44% | 1.29% | 63.91 |
Financial data is updated regularly. All figures are in the company's reporting currency.